Development and characterization of a
Animals
Antigens, Neoplasm
/ analysis
Carcinoma, Pancreatic Ductal
/ diagnostic imaging
Dose-Response Relationship, Drug
Drug Development
Gallium Radioisotopes
Humans
Integrins
/ analysis
Male
Mice
Mice, Inbred ICR
Molecular Probes
/ chemical synthesis
Molecular Structure
Neoplasms, Experimental
/ diagnostic imaging
Pancreatic Neoplasms
/ diagnostic imaging
Peptides
/ chemical synthesis
Positron-Emission Tomography
Structure-Activity Relationship
Tumor Cells, Cultured
Pancreatic Neoplasms
A20FMDV2 peptide
Gallium-68
Pancreatic ductal adenocarcinoma
Positron emission tomography
αvβ6 integrin
Journal
Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298
Informations de publication
Date de publication:
01 01 2020
01 01 2020
Historique:
received:
04
09
2019
revised:
25
10
2019
accepted:
27
10
2019
pubmed:
20
11
2019
medline:
28
1
2021
entrez:
20
11
2019
Statut:
ppublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC) is known to be one of the most lethal cancers. Since the majority of patients are diagnosed at an advanced stage, development of a detection method for PDAC at an earlier stage of disease progression is strongly desirable. Integrin α
Identifiants
pubmed: 31740201
pii: S0968-0896(19)31485-3
doi: 10.1016/j.bmc.2019.115189
pii:
doi:
Substances chimiques
Antigens, Neoplasm
0
Gallium Radioisotopes
0
Integrins
0
Molecular Probes
0
Peptides
0
integrin alphavbeta6
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
115189Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.